Developing a vaccine to prevent hepatitis C transmission
Admin Core
This study is working on a new vaccine to help prevent the spread of hepatitis C, and it aims to bring together different research teams to make sure the project runs smoothly, which could lead to better protection for patients in the future.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11015058 on NIH RePORTER |
What this research studies
This research focuses on creating a vaccine aimed at stopping the transmission of the hepatitis C virus (HCV). The project is managed by an administrative core that oversees various research activities, including fiscal management, communication between research teams, and scientific oversight. The core facilitates collaboration among different research sites and ensures that progress is monitored effectively. Patients may benefit from advancements in vaccine development that could lead to better prevention of HCV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of hepatitis C infection or those who are currently infected and seeking preventive options.
Not a fit: Patients who are not at risk for hepatitis C or those who have already been cured of the infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a widely effective vaccine that significantly reduces the transmission of hepatitis C.
How similar studies have performed: Previous research efforts in vaccine development for hepatitis C have shown promise, indicating that this approach has potential based on earlier successes.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Law, Mansun — Scripps Research Institute, the
- Study coordinator: Law, Mansun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.